1.0Cluster Transfronterizo Biotecnológicohttps://transferenciabiotech.org/en/adminhttps://transferenciabiotech.org/en/author/admin/rich600338<blockquote class="wp-embedded-content" data-secret="89LyrZua0m"><a href="https://transferenciabiotech.org/en/investment/inveready/">Inveready</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://transferenciabiotech.org/en/investment/inveready/embed/#?secret=89LyrZua0m" width="600" height="338" title="“Inveready” — Cluster Transfronterizo Biotecnológico" data-secret="89LyrZua0m" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://transferenciabiotech.org/wp-includes/js/wp-embed.min.js </script> https://transferenciabiotech.org/wp-content/uploads/2019/04/Inveready.jpg600400Inveready is a Venture Capital covering Seed and Series A stages for companies in the Life Sciences sector. Inveready has more than 30 invested companies in this sector. We focus on companies that develop therapies in human health, in its most initial phases. We also invest in companies that already have some business traction and need financing for their organic or inorganic growth (acquisitions of other companies).